HHV Biotech
PrivateCompany Overview
HHV Biotech is a biotechnology company that develops innovative treatments for biofilm-related infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HHV Biotech Comparables
Compare HHV Biotech with similar companies based on industry and business-model similarity.
HHV Biotech Funding Rounds
Historical fundraising activity
HHV Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Surmount Ventures | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 22, 2026
Grew 100% QoQ from 3 to 6 employees.
- Jan 6, 2026
Monthly visitors increased 111% MoM, reaching 2.8K.
HHV Biotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about HHV Biotech's valuation, stock price, and market status.